21 C.F.R. § 524.2338

Terbinafine and betamethasone acetate.

Last amended: 2024Year: 2026Length: 95 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 524.2338 (2026)

(a) Specifications. Each milliliter of gel contains 10 milligrams (mg) terbinafine and 1 mg betamethasone acetate. (b) Sponsor. See No. 043264 in § 510.600(c) of this chapter. (c) Conditions of use in dogs —(1) Amount. Administer one dose (1 tube) per affected ear(s) and repeat administration in 7 days. (2) Indications for use. For the treatment of otitis externa in dogs, associated with susceptible strains of yeast ( Malassezia pachydermatis ). (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [89 FR 42360, May 15, 2024]
Cross-references to the CFR
510.600
21 C.F.R. § 524.2338: Terbinafine and betamethasone acetate. | Justis AI